specialty pharmaceuticals business
Indivior aims to move primary listing from London to New York: Drugmaker says switch would attract more US investors
ft.com/content/0feaa62e-f574-43dc-adcc-8863861aa606
Paid articlePaid
Indivior: Opioid Use Disorder Market Growth Could Deliver 59% Upside: Indivior's key drug Sublocade continues to grow and eventually delivers peak sales of $1 ...
seekingalpha.com/article/4658775-indivior-opioid-use-disorder-market-growth-could-deliver-59-percent-upside
Paid articlePaid
London court throws out Suboxone representative lawsuit: London's High Court threw out a representative lawsuit against Reckitt Benckiser (RKT ...
reuters.com/world/uk/london-court-throws-out-suboxone-representative-lawsuit-2023-12-05/
Reckitt Benckiser, Indivior, ask London court to throw out Suboxone lawsuit: Consumer goods giant Reckitt Benckiser (RKT.L) and Indivior (INDV ...
reuters.com/world/uk/reckitt-benckiser-indivior-ask-london-court-throw-out-suboxone-lawsuit-2023-11-20/
US to Defend Against Fentanyl Terrorism With Opioid Overdose Antidote: Drugmaker Indivior Plc clinched a US contract worth up to $111 million for its opioid ...
bloomberg.com/news/articles/2023-11-08/us-to-defend-against-fentanyl-terrorism-with-overdose-antidote
Indivior to pay $385 million to end final Suboxone monopoly lawsuits: Indivior (INDV.L) on Monday agreed to pay $385 million to settle lawsuits in the U.S ...
reuters.com/legal/indivior-pay-385-mln-end-suboxone-monopoly-lawsuits-2023-10-23/
Indivior to pay $30 million to settle health plans' Suboxone claims: Indivior (INDV.L) has agreed to pay $30 million to settle a class action lawsuit filed in a ...
reuters.com/legal/indivior-pay-30-million-settle-health-plans-suboxone-claims-2023-08-21/
Morgan Stanley picks ‘particularly high conviction’ global stocks it says the rest of the market is missing
cnbc.com/2023/07/21/morgan-stanley-particularly-high-conviction-stocks-to-beat-the-market.html
Paid articlePaid Morgan Stanley’s Secker Says UK Assets Are World’s Cheapest: Sentiment around the UK economy has been so poor that the nation’s stocks and credit are now the ...
bloomberg.com/news/articles/2023-07-10/morgan-stanley-strategists-say-uk-assets-are-world-s-cheapest
Indivior opioid settlement makes purer M&A case: Indivior (INDV.L) is one step closer to becoming a takeover target. On Friday, the $3 billion maker of ...
reuters.com/breakingviews/indivior-opioid-settlement-makes-purer-ma-case-2023-06-05/
US FDA approves Opiant's spray for reversing opioid-related overdoses: The U.S. Food and Drug Administration on Monday approved Opiant Pharmaceuticals Inc's ...
reuters.com/world/us/us-fda-approves-opiants-spray-reversing-opioid-related-overdoses-2023-05-22/
Addiction drug maker will pay more than $102 million fine for stifling competition
npr.org/2023/06/02/1179757051/suboxone-invidior-addiction-drug
Iowa to receive over $1M of $100M settlement with opioid treatment manufacturer: Iowa Attorney General Brenna Bird joined 40 Attorney Generals across the country ...
desmoinesregister.com/story/news/crime-and-courts/2023/06/07/indivior-to-pay-over-1-mil-to-iowa-following-country-wide-lawsuit-opioid-addiction-suboxone/70299763007/
MO, KS were on $102.5M opioid treatment drug settlement. How much does each state get?
kansascity.com/news/politics-government/article276047191.html
New nasal spray to reverse fentanyl and other opioid overdoses gets FDA approval: U.S. health regulators have approved a new nasal spray to reverse overdoses due ...
detroitnews.com/story/news/world/2023/05/22/new-nasal-spray-to-reverse-fentanyl-and-other-opioid-overdoses-gets-fda-approval/70245957007/
More than 100 Greater Richmond companies honored as Top Workplaces: Markel, Indivior, Virginia Workers’ Compensation Commission and Better Homes and Gardens Real ...
richmond.com/news/local/business/more-than-100-greater-richmond-companies-honored-as-top-workplaces/article_4e0bf4a2-f5cf-11ed-9963-5b23937f4354.html
Paid articlePaid Indivior earns Top Workplace with its mission to help a stigmatized patient population
richmond.com/business/local/top-workplaces/indivior-earns-top-workplace-with-its-mission-to-help-a-stigmatized-patient-population/article_1d2eb8f6-e099-11ed-8996-4b9399ed6688.html
Paid articlePaid
FDA Approves New Nasal Spray to Reverse Opioid Overdoses: It’s not yet clear how the drug, Opvee, will be used differently than naloxone, and some experts see ...
time.com/6281972/opvee-nasal-spray-opioid-overdose/
U.S. Senator Warren 'particularly concerned' about Amgen, Indivior deals: Sen. Elizabeth Warren, an outspoken critic of corporate consolidation, wrote to the U.S ...
reuters.com/markets/deals/warren-tells-ftc-she-is-particularly-concerned-about-amgen-indivior-deals-2023-01-26/
Indivior completes its acquisition of Narcan-maker Opiant Pharmaceuticals: Chesterfield-based Indivior PLC completed a significant step in its journey to become ...
richmond.com/business/local/indivior-completes-its-acquisition-of-narcan-maker-opiant-pharmaceuticals/article_3bf353c0-b93c-11ed-8b7e-53366f4b8aae.html
Chesterfield-based Indivior targets spot at top of addiction treatment industry, carries lingering legal troubles
richmond.com/business/local/chesterfield-based-indivior-targets-spot-at-top-of-addiction-treatment-industry-carries-lingering-legal-troubles/article_0c681cb4-c89b-5bbe-abe4-ba2552dca59d.html
Richmond-area-based pharma company Indivior buys NARCAN developer Opiant, aims to launch new overdose reversal agent
richmond.com/business/richmond-area-based-pharma-company-indivior-buys-narcan-developer-opiant-aims-to-launch-new-overdose/article_e959f12e-baf9-527a-9457-6f711ae203bf.html
Indivior must face states' monopoly claim over opioid addiction drug: Drugmaker Indivior Inc must face a lawsuit by 42 state attorneys general accusing it of ...
reuters.com/legal/litigation/indivior-must-face-states-monopoly-claim-over-opioid-addiction-drug-2022-08-23/
Indivior sees ‘huge opportunity’ for drug targeting cannabis misuse: Biotech company hopes to win first US approval for medicine aimed at people addicted to ...
ft.com/content/35a31737-bb62-45aa-82a4-115d742374ab
Dr Reddy’s settles patent litigation with Indivior, Aquestive Therapeutics: On June 28, 2022, a US Court dismissed all claims and counterclaims pending in the ...
financialexpress.com/healthcare/dr-reddys-settles-patent-litigation-with-indivior-aquestive-therapeutics/2577810/
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics